ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 679 • 2016 ACR/ARHP Annual Meeting

    Diagnostic Value of MR Enterography As a Complementary Intervention to Colonoscopy in Axial Spondylarthritis Patients with Chronic Non-Bloody Diarrhea

    Ilkay Ergenç1, Ali Ugur Unal2, Zeynep Erturk3, Gulsum Oguz4, Yasemin Yalcinkaya5, Nese Imeryuz6, Rabia Ergelen7, Gazanfer Ekinci8, Nevsun Inanc5, Cigdem Celikel9, Haner Direskeneli10, Hakan Akin11 and Pamir Atagunduz5, 1Internal Medicine, Marmara University School of Medicine, Istanbul, Turkey, 2Marmara University, School of Medicine, Rheumatology, Istanbul, Turkey, 3Rheumatology, Marmara University Faculty of Medicine, Istanbul, Turkey, 4Rheumatology, Marmara University School of Medicine, Istanbul, Turkey, 5Department of Rheumatology, Marmara University Faculty of Medicine, Istanbul, Turkey, 6Gastroenterology, Marmara University, Istanbul, Turkey, 7Radiology, Marmara University School of Medicine, Istanbul, Turkey, 8Marmara University Faculty of Medicine Department of Radiology, Istanbul, Turkey, 9Pathology, Marmara University School of Medicine, Istanbul, Turkey, 10Rheumatology, Marmara University, School of Medicine, Istanbul, Turkey, 11Gastroenterology, Marmara University School of Medicine, Istanbul, Turkey

    Background/Purpose: Chronic intermittent diarrhea (CID) is a common clinical problem in axial spondylarthritis (axSpA) patients and eventually up to 13% of these are diagnosed with…
  • Abstract Number: 680 • 2016 ACR/ARHP Annual Meeting

    Development and Preliminary Validation of the Computed Tomography Sacroiliac Structural Score for Assessment of Structural Lesions in Axial Spondyloarthritis

    Walter Maksymowych1, Marie Raynal2, Damien Loeuille3, Maria Antonietta D'Agostino4, Joel Paschke5 and Robert G Lambert6, 1Medicine, University of Alberta, Edmonton, AB, Canada, 2Rheumatology, CHRU Nancy, Nancy, France, 3Rheumatology, CHRU Vandoeuvre les Nancy, Nancy, France, 4Rheumatology, Versailles-Saint Quentin en Yvelines University, Boulogne-Billancourt, France, 5CaRE Arthritis, Edmonton, AB, Canada, 6Radiology, University of Alberta, Edmonton, AB, Canada

    Background/Purpose: Computed tomography (CT) is considered the imaging benchmark for the assessment of certain structural lesions in the sacroiliac joints (SIJ) of patients with axial…
  • Abstract Number: 681 • 2016 ACR/ARHP Annual Meeting

    Can Bridging Syndesmophytes Independantly Affect Spinal Mobility?

    Ismail Sari1, Ahmed Omar1, Mansour Alazmi1, Renise Ayearst2, Robert D Inman1 and Nigil Haroon1, 1Rheumatology, Toronto Western Hospital, University of Toronto, Spondylitis Clinic, Toronto, ON, Canada, 2Medicine, University Health Network, Toronto, ON, Canada

    Background/Purpose: One of the hallmark characteristics of the disease is new bone formation that manifests as syndesmophytes and spinal fusion. Spinal fusion results from bridging…
  • Abstract Number: 682 • 2016 ACR/ARHP Annual Meeting

    Which Is the Most Reliable Imaging Method for Detection of Structural Changes in the Sacroiliac Joints of Patients with Ankylosing Spondylitis? a Cross-Sectional Study Comparing MRI, CT and Conventional Radiographs

    Xenofon Baraliakos1, Florian Hoffmann2, Xiaohu Deng3, Yanyan Wang4, Feng Huang5 and Jürgen Braun2, 1Rheumatology, Rheumazentrum Ruhrgebiet, Herne, Germany, 2Rheumazentrum Ruhrgebiet, Herne, Germany, 3Chinese PLA General Hospital, Chinese PLA General Hospital, Beijing, China, 4Rheumatology, Chinese PLA General Hospital, Beijing, China, 5Chinese PLA General Hospital, Beijing, China

    Background/Purpose: Magnetic resonance imaging (MRI) is the gold standard for detection of inflammation and fat metaplasia in the sacroiliac joints (SIJ) and the spine of…
  • Abstract Number: 683 • 2016 ACR/ARHP Annual Meeting

    Risk Factors of Uveitis in Ankylosing Spondylitis

    Feng Wang1, Qin Xue2, Li Sun3 and Niansong Wang4, 1Nephrology and Rheumatology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China, 2Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China, 3Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing, China, 4Shanghai Jiao Tong University Affiliated Sixth People's Hospital, shanghai, China

    Background/Purpose: Uveitis is the most common extra-articular manifestation in patients with ankylosing spondylitis (AS).The prevalence and characteristics of uveitis in AS have been studied in previous literatures while…
  • Abstract Number: 684 • 2016 ACR/ARHP Annual Meeting

    Subchondral Bone Sclerosis on Computed Tomography – Does It Have Any Value in the Diagnosis of Inflammatory Sacroiliitis or Is It a Non-Specific Finding?

    Omar Azmat1, Robert G. Lambert2, Zaid Jibri3 and Walter Maksymowych4, 1Diagnostic Imaging, University of Alberta, Edmonton, AB, Canada, 2Radiology, University of Alberta, Edmonton, AB, Canada, 3Diagnostic Imaging, The Ottawa Hospital, Ottawa, ON, Canada, 4Medicine, University of Alberta, Edmonton, AB, Canada

            Background/Purpose: Sclerosis in the sacroiliac joints (SIJ) on radiography and computed tomography (CT) is common but widely considered a non-specific finding…
  • Abstract Number: 685 • 2016 ACR/ARHP Annual Meeting

    Paradoxical Psoriasis Secondary to Anti-Tnfa Agents in Patients with Ankylosing Spondylitis: A Nationwide Population-Based Cohort Study

    Ki-Jo Kim1, Jung Min Bae2, Young Bin Joo3, In-Woon Baek4, Kyung-Su Park3 and Chul-Soo Cho4, 1Internal Medicine, St. Vincent’s Hospital, The Catholic University of Korea, Suwon, Korea, The Republic of, 2Dermatology, St. Vincent's Hospital, The Catholic University of Korea, Suwon, Korea, The Republic of, 3Internal Medicine, St. Vincent's Hospital, The Catholic University of Korea, Suwon, Korea, The Republic of, 4Internal Medicine, Yeouido St. Mary's Hospital, The Catholic University of Korea, Seoul, South Korea

    Background/Purpose:  Anti-tumor necrosis factor-alpha (anti-TNFa) agents are established as the mainstay of treatment for ankylosing spondylitis (AS). Recently, paradoxical induction or exacerbation of psoriatic skin…
  • Abstract Number: 686 • 2016 ACR/ARHP Annual Meeting

    Development and Evaluation of the Combined Ankylosing Spondylitis Spine Score (CASSS) for the Assessment of Spinal Radiographic Outcome

    Fiona Maas1, Anneke Spoorenberg1,2, Elisabeth Brouwer1, Hendrika Bootsma3, Reinhard Bos2, Freke Wink2 and Suzanne Arends1,2, 1Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, 2Rheumatology, Medical Center Leeuwarden, Leeuwarden, Netherlands, 3Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, The Netherlands, Groningen, Netherlands

    Background/Purpose: Spinal radiographic progression is a highly variable process in ankylosing spondylitis (AS). Our aim was to develop a combined AS spine score (CASSS) in…
  • Abstract Number: 687 • 2016 ACR/ARHP Annual Meeting

    Safety and Efficacy of Certolizumab Pegol over 204 Weeks in Patients with Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis

    Atul A. Deodhar1, Maxime Dougados2, Robert Landewé3, Joachim Sieper4, Walter Maksymowych5, Martin Rudwaleit6, Filip van Den Bosch7, Jürgen Braun8, Philip J Mease9, Alan Kivitz10, Jessica Walsh11, Owen Davies12, Bengt Hoepken13, Luke Peterson14 and Désirée van der Heijde15, 1Divison of Arthritis and Rheumatic Diseases, Oregon Health and Science University, Portland, OR, 2Rheumatology B Department, Paris-Descartes University, APHP, Cochin Hospital, Paris, France, 3Academic Medical Center, Amsterdam and Zuyderland Medical Center, Heerlen, Netherlands, 4Rheumatology Department, Charité – University Medicine Berlin, Berlin, Germany, 5Department of Medicine, University of Alberta, Edmonton, AB, Canada, 6Klinikum Bielefeld and Charité – University Medicine Berlin, Berlin, Germany, 7University Hospital Ghent, Ghent, Belgium, 8Rheumazentrum Ruhrgebiet, Herne, Germany, 9Swedish Medical Center and University of Washington, Seattle, WA, 10Altoona Center for Clinical Research, Duncansville, PA, 11Division of Rheumatology, University of Utah School of Medicine, Salt Lake City, UT, 12UCB Pharma, Slough, United Kingdom, 13UCB Pharma, Monheim, Germany, 14UCB Pharma, Raleigh, NC, 15Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands

    Background/Purpose: RAPID-axSpA (NCT01087762) investigated the efficacy and safety of certolizumab pegol (CZP) in patients (pts) with axial spondyloarthritis (axSpA), including ankylosing spondylitis (AS) and non-radiographic…
  • Abstract Number: 688 • 2016 ACR/ARHP Annual Meeting

    Spondyloarthritis Research Consortium of Canada (SPARCC) Baseline MRI SI Joint Score ≥2 Better Predicts Response to Golimumab Than Does Assessment of Spondyloarthritis International Society (ASAS) MRI Positivity in Nonradiographic Axial Spondyloarthritis

    Walter Maksymowych1, Anjela Tzontcheva2, George Philip2, Gina Bergman2, Susan Huyck2 and Sean P. Curtis2, 1Medicine, University of Alberta, Edmonton, AB, Canada, 2Merck & Co., Inc., Kenilworth, NJ

    Background/Purpose: Golimumab (GLM) was shown to be effective for nonradiographic axial spondyloarthritis (nr-axSpA) in a randomized, double-blind, placebo-controlled, phase 3 study (GO-AHEAD; NCT01453725).1 The SPondyloArthritis…
  • Abstract Number: 689 • 2016 ACR/ARHP Annual Meeting

    Relationship Between Infliximab Serum Concentrations and Risk of Infections in Patients Treated for Spondyloarthritis

    Theodora Bejan-Angoulvant1, David Ternant2, Fadela Daoued3, Frédéric Medina3, Louis Bernard4, Saloua Mammou3, Gilles Paintaud2 and Denis Mulleman5, 1Service de Pharmacologie Clinique, CHRU de Tours, Université François-Rabelais de Tours, CNRS 7292, CHRU de Tours, Tours, France, 2Laboratoire de Pharmacologie-Toxicologie, Université François-Rabelais de Tours, CNRS 7292, CHRU de Tours, Tours, France, 3Service de Rhumatologie, Université François-Rabelais de Tours, CHRU de Tours, Tours, France, 4Service des Maladies Infectieuses, Université François-Rabelais de Tours, CHRU de Tours, Tours, France, 5Service de Rhumatologie, Rheumatology department, François-Rabelais University, CNRS 7292, CHRU de Tours, Tours, France

    Background/Purpose: Tumour necrosis factor alpha inhibitors are effective in reducing inflammation in rheumatic diseases while increasing the risk of infections. We aimed to study the…
  • Abstract Number: 690 • 2016 ACR/ARHP Annual Meeting

    Increase in Serum Leptin Levels Is Associated with Radiographic Progression of Male Patients with Ankylosing Spondylitis: A 2-Year Longitudinal Study

    Seung-Geun Lee1, Eun-Kyoung Park2, Ji-Heh Park1, Hee-Sang Tag3 and Geun-Tae Kim4, 1Internal Medicine, Pusan National University School of Medicine, Pusan National University Hospital, Busan, Korea, The Republic of, 2Division of Rheumatology, Department of Internal Medicine, Pusan National University School of Medicine, Busan, Korea, The Republic of, 3Division of Rheumatology, Department of Internal Medicine, Kosin University College of Medicine, Busan, South Korea, 4Kosin University College of Medicine, Busan, South Korea

    Background/Purpose:  The immunomodulatory effects of adipokines have been extensively studied in rheumatic diseases, there is a paucity of information regarding their effects on bone metabolism.…
  • Abstract Number: 691 • 2016 ACR/ARHP Annual Meeting

    ASAS Health Index for Patients with Spondyloarthritis: Translation into Spanish, Validation, Reliability and Construct Validity

    Wilson Bautista-Molano1,2, Robert Landewé3, Uta Kiltz4, Rafael Valle-Oñate5 and Désirée van der Heijde6, 1Rheumatology, Leiden University Medical Center, Bogotá, Colombia, 2Rheumatology Department School of Medicine HMC / UMNG, Bogotá, Colombia, 3Clinical Immunology and Rheumatology, Amsterdam Rheumatology Center, Amsterdam, Netherlands, 4Rheumazentrum Ruhrgebiet, Herne, Germany, 5Rheumatology, Rheumatology Department School of Medicine HMC / UMNG, Bogota, Colombia, 6Rheumatology, Leiden University Medical Center, Leiden, Netherlands

    Background/Purpose: The aim of the study was to develop and validate a Spanish-language translation of the ASAS Heath Index (ASAS-HI) testing its reliability, construct validity…
  • Abstract Number: 692 • 2016 ACR/ARHP Annual Meeting

    Efficacy and Safety of Biological Therapy and Target Synthetic Dmards: A Systematic Literature Review Informing the 2016 Update of the ASAS/EULAR Recommendations for the Management of Axial Spondyloarthritis

    Alexandre Sepriano1, Andrea Regel2, Désirée van der Heijde1, Jürgen Braun2, Xenofon Baraliakos2, Robert Landewé3, Filip van Den Bosch4 and Sofia Ramiro1, 1Leiden University Medical Center, Leiden, Netherlands, 2Rheumazentrum Ruhrgebiet, Herne, Germany, 3Department of Rheumatology, Amsterdam Rheumatology Center, Amsterdam, Netherlands, 4Rheumatology, Ghent University Hospital, Gent, Belgium

    Background/Purpose: As part of the update of the ASAS/EULAR recommendations for the management of axSpA, we performed a systematic literature review to assess the efficacy…
  • Abstract Number: 693 • 2016 ACR/ARHP Annual Meeting

    The Prevalence of Axial and Peripheral Spondyloarthritis in Inflammatory Bowel Disease: A Systematic Review & Meta-Analysis

    Maren C. Karreman1,2, Jolanda J. Luime3, Johanna M.W. Hazes2 and Angelique E.A.M. Weel1, 1Rheumatology, Maasstad Hospital, Rotterdam, Netherlands, 2Rheumatology, Erasmus University Medical Center, Rotterdam, Netherlands, 3Rheumatology, Erasmus Medical Centre, Rotterdam, Netherlands

    Background/Purpose: Inflammatory Bowel Disease (IBD) is a chronic disease that affects up to 0.5% of the population, comprising both Crohn’s Disease (CD) and ulcerative colitis…
  • « Previous Page
  • 1
  • …
  • 1461
  • 1462
  • 1463
  • 1464
  • 1465
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology